Copyright © 2001 by the European Society of Cardiology.
Editorial
The Brugada syndrome: diagnostic criteria and cellular mechanisms
Masonic Medical Research Laboratory, Utica, New York, U.S.A.
References
- Viskin S, Lesh MD, Eldar M. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol. 1997;8:11151120[Web of Science][Medline]
- Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:13911396[Abstract]
- Antzelevitch C, Brugada P, Brugada J. The Brugada Syndrome. Armonk: Futura Publishing Company, Inc; 1999.
- Alings M, Wilde A. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation. 1999;99:666673
[Free Full Text] - Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol. 2000;:
- Nademanee K, Veerakul G, Nimmannit S. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96:25952600
[Abstract/Free Full Text] - Priori SG, Napolitano C, Glordano U. Brugada syndrome and sudden cardiac death in children. Lancet. 2000;355:808809[CrossRef][Web of Science][Medline]
- Corrado D, Buja G, Basso C. What is the Brugada syndrome? Cardiol Rev. 1999;7:191195[Medline]
- Brugada R, Brugada J, Antzelevitch C. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 2000;101:510515
[Abstract/Free Full Text] - Remme CA, Wever EFD, Wilde AAM, Derksen R, Hauer RNW. Diagnosis and long-term follow-up of Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J. 2001;22:400409
[Abstract/Free Full Text] - Viskin S, Fish R, Eldar M. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls [see comments]. Heart. 2000;84:3136
[Abstract/Free Full Text] - Chen Q, Kirsch GE, Zhang D. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature. 1998;392:293296[CrossRef][Medline]
- Yan GX, Antzelevitch C. Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation. 1999;100:16601666
[Abstract/Free Full Text] - Rook MB, Alshinawi CB, Groenewegen WA. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res. 1999;44:507517
[Abstract/Free Full Text] - Dumaine R, Towbin JA, Brugada P. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803809
[Abstract/Free Full Text] - Deschenes I, Baroudi G, Berthet M. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes [see comments]. Cardiovasc Res. 2000;46:5565[CrossRef][Web of Science][Medline]
- Bezzina C, Veldkamp MW, van Den Berg MP. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res. 1999;85:12061213
[Abstract/Free Full Text] - Alshinawi C, Mannens M, Wilde AAM. Mutations in the human cardiac sodium channel gene (SCN5A) in patients with Brugada syndrome (Abstr). Eur Heart J. 1998;19:78
- Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation. 1996;93:372379
[Abstract/Free Full Text] - Gussak I, Antzelevitch C, Bjerregaard P. The Brugada syndrome: clinical, electrophysiological and genetic aspects. J Am Coll Cardiol. 1999;33:515
[Abstract/Free Full Text] - Miyazaki T, Mitamura H, Miyoshi S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27:10611070[Abstract]
- Lukas A, Antzelevitch C. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine. Cardiovasc Res. 1996;32:593603[CrossRef][Web of Science][Medline]
- Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: Physiological, pharmacological and clinical implications. Page E, Fozzard HA, Solaro RJ. Handbook of Physiology. The Heart. New York: Oxford University Press; 2000.
- Antzelevitch C. Ion channels and ventricular arrhythmias. Cellular and ionic mechanisms underlying the Brugada syndrome. Curr Opin Cardiol. 1999;14:274279[CrossRef][Web of Science][Medline]
- Tarin N, Farre J, Rubio JM. Brugada-like electrocardiographic pattern in a patient with a mediastinal tumor. PACE. 1999;22:12641266
- Carlsson J, Erdogan A, Schulte B. Possible role of left ventricular programmed stimulation in Brugada syndrome. PACE. 2000;:
- Litovsky SH, Antzelevitch C. Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ Res. 1990;67:615627
[Abstract/Free Full Text] - Krishnan SC, Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 Reentry? Circulation. 1993;87:562572
[Abstract/Free Full Text] - Matsuo K, Shimizu W, Kurita T. Increased dispersion of repolarization time determined by monophasic action potentials in two patients with familial idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol. 1998;9:7483[Web of Science][Medline]
- Xiao YF, Wright SN, Wang GK. Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels [In Process Citation]. Am J Physiol Heart Circ Physiol. 2000;279:H35H46
[Abstract/Free Full Text] - Kuryshev YA, Brittenham GM, Fujioka H. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease. Circulation. 1999;100:675683
[Abstract/Free Full Text] - Shimizu W, Matsuo K, Takagi M. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol. 2000;11:396404[Web of Science][Medline]
This article has been cited by other articles:
![]() |
S. Nagase, K. F. Kusano, H. Morita, N. Nishii, K. Banba, A. Watanabe, S. Hiramatsu, K. Nakamura, S. Sakuragi, and T. Ohe Longer Repolarization in the Epicardium at the Right Ventricular Outflow Tract Causes Type 1 Electrocardiogram in Patients With Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1154 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Watanabe, K. Fukushima Kusano, H. Morita, D. Miura, W. Sumida, S. Hiramatsu, K. Banba, N. Nishii, S. Nagase, K. Nakamura, et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome Eur. Heart J., July 1, 2006; 27(13): 1579 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Castro Hevia, C. Antzelevitch, F. Tornes Barzaga, M. Dorantes Sanchez, F. Dorticos Balea, R. Zayas Molina, M. A. Quinones Perez, and Y. Fayad Rodriguez Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada Syndrome J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1828 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Hermida, I. Denjoy, G.èv. Jarry, S. Jandaud, C. Bertrand, and J. Delonca Electrocardiographic predictors of Brugada type response during Na channel blockade challenge Europace, January 1, 2005; 7(5): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Hermida, I. Denjoy, J. Clerc, F. Extramiana, G. Jarry, P. Milliez, P. Guicheney, S. Di Fusco, J.-L. Rey, B. Cauchemez, et al. Hydroquinidine therapy in Brugada syndrome J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1853 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kimura, T. Kobayashi, S. Owada, K. Ashikaga, T. Higuma, S. Sasaki, A. Iwasa, S. Motomura, and K. Okumura Mechanism of ST Elevation and Ventricular Arrhythmias in an Experimental Brugada Syndrome Model Circulation, January 6, 2004; 109(1): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morita, S. T. Morita, S. Nagase, K. Banba, N. Nishii, Y. Tani, A. Watanabe, K. Nakamura, K. F. Kusano, T. Emori, et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1624 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Pitzalis, M. Anaclerio, M. Iacoviello, C. Forleo, P. Guida, R. Troccoli, F. Massari, F. Mastropasqua, S. Sorrentino, A. Manghisi, et al. QT-interval prolongation inright precordial leads: an additional electrocardiographic hallmark of Brugada syndrome J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1632 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Hermida, A. Leenhardt, B. Cauchemez, I. Denjoy, G. Jarry, F. Mizon, P. Milliez, J.-L. Rey, P. Beaufils, and P. Coumel Decreased nocturnal standard deviation of averaged NN intervals: An independent marker to identify patients at risk in the Brugada Syndrome Eur. Heart J., November 2, 2003; 24(22): 2061 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Patruno, D. Pontillo, A. Achilli, G. Ruggeri, and G. Critelli Electrocardiographic pattern of Brugada syndrome disclosed by a febrile illness: clinical and therapeutic implications Europace, January 1, 2003; 5(3): 251 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Late potentials and the Brugada syndrome J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1996 - 1999. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




